Reduced-toxicity conditioning with fludarabine, oncedaily intravenous busulfan, and antithymocyte globulins prior to allogeneic stem cell transplantation: Results of a multicenter prospective phase 2 trial (vol 121, pg 562, 2015)

Mohty M.; Malard F.; Blaise D.; Milpied N.; Furst S.; Tabrizi R.; Guillaume T.; Vigouroux S.; El-Cheikh J.; Delaunay J.; Le Gouill S.; Moreau P.; Labopin M.; Chevallier P.

首页> 外文期刊>Cancer: A Journal of the American Cancer Society >Reduced-toxicity conditioning with fludarabine, oncedaily intravenous busulfan, and antithymocyte globulins prior to allogeneic stem cell transplantation: Results of a multicenter prospective phase 2 trial (vol 121, pg 562, 2015)

【24h】

Reduced-toxicity conditioning with fludarabine, oncedaily intravenous busulfan, and antithymocyte globulins prior to allogeneic stem cell transplantation: Results of a multicenter prospective phase 2 trial (vol 121, pg 562, 2015)

机译：异基因干细胞移植前使用氟达拉滨，每天一次静脉注射白消安和抗胸腺细胞球蛋白降低毒性的条件：一项多中心前瞻性2期试验的结果（第121卷，第562页，2015年）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Cancer: A Journal of the American Cancer Society》 |2015年第5期|共1页
作者
Mohty M.; Malard F.; Blaise D.; Milpied N.; Furst S.; Tabrizi R.; Guillaume T.; Vigouroux S.; El-Cheikh J.; Delaunay J.; Le Gouill S.; Moreau P.; Labopin M.; Chevallier P.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献

1. Reduced-toxicity conditioning with fludarabine, oncedaily intravenous busulfan, and antithymocyte globulins prior to allogeneic stem cell transplantation: Results of a multicenter prospective phase 2 trial (vol 121, pg 562, 2015) [J] . Mohty M., Malard F., Blaise D., Cancer: A Journal of the American Cancer Society . 2015,第5期

机译：异基因干细胞移植前使用氟达拉滨，每天一次静脉注射白消安和抗胸腺细胞球蛋白降低毒性的条件：一项多中心前瞻性2期试验的结果（第121卷，第562页，2015年）
2. The efficacy and safety of a new reduced-toxicity conditioning with 4 days of once-daily 100mg/m(2) intravenous busulfan associated with fludarabine and antithymocyte globulins prior to allogeneic stem cell transplantation in patients with high-risk myelodysplastic syndrome or acute leukemia [J] . Wanquet Anne, Crocchiolo Roberto, Furst Sabine, Leukemia and lymphoma . 2016,第10期

机译：异基因干细胞移植前高风险骨髓增生异常综合征或急性白血病患者每天进行一次为期4天，每天一次100mg / m（2）静脉白消安联合氟达拉滨和抗胸腺细胞球蛋白治疗的新型低毒治疗的安全性
3. Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial | Haematologica [J] . Patrice Chevallier, Myriam Labopin, Gérard Socié, Haematologica . 2014,第9期

机译：异体干细胞移植前使用含氯法拉滨-白消安的毒性降低的调理方案的结果：前瞻性2期CLORIC试验|血液学
4. Results from a clofarabine-busulfan-containing reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial [O] . Patrice Chevallier, Myriam Labopin, Gérard Socié, 2014

机译：同种异体干细胞移植前含氯法拉滨-白消安的毒性降低的调理方案的结果：前瞻性2期CLORIC试验
5. Allogeneic Stem Cell Transplantation from Matched Related Donor in Patients Over the Age of 55 Years After Reduced Intensity Conditioning Associating Fludarabine-Iv Busulfan and Rabbit-Antithymocyte Globulin: A Prospective Multicenter Phase II Clinical Trial with Socio Economic Evaluation [O] . Blaise D., Mohty M., Milpied N., 2012

机译：氟达拉滨-IV白消安和兔抗胸腺细胞球蛋白降低强度调节后55岁以上患者从匹配相关供体的同种异体干细胞移植：一项具有社会经济评价的前瞻性多中心II期临床试验

Reduced-toxicity conditioning with fludarabine, oncedaily intravenous busulfan, and antithymocyte globulins prior to allogeneic stem cell transplantation: Results of a multicenter prospective phase 2 trial (vol 121, pg 562, 2015)

著录项

相似文献

相关主题

期刊订阅